Pilot Study of a Smartphone-Based Vaping Cessation Program
NCT05642598 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 73
Last updated 2025-01-31
Summary
Prospective, open label, single center clinical study enrolling up to 100 participants to evaluate the effect of the Pivot vaping cessation program.
Conditions
- Vaping Cessation
Interventions
- BEHAVIORAL
-
Pivot for Vape
"Pivot for Vape" vaping cessation smartphone app and program
Sponsors & Collaborators
-
Pivot Health Technologies Inc.
lead INDUSTRY
Principal Investigators
-
Jennifer Marler, MD · Pivot Health Technologies Inc.
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-02-07
- Primary Completion
- 2024-05-23
- Completion
- 2024-05-23
Countries
- United States
Study Locations
More Related Trials
-
Varenicline For Nicotine Vaping Cessation In Non Smoker Vaper Adolescents
NCT04602494 ·Status: TERMINATED ·Phase: PHASE4
-
Varenicline for the Treatment of Smokeless Tobacco
NCT00813917 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Using Reduced Nicotine Cigarettes in Men and Women Smokers to Combat Nicotine Addiction
NCT00264342 ·Status: COMPLETED
-
Effects of Varenicline on Brain Activity During Nicotine Abstinence
NCT00602927 ·Status: COMPLETED ·Phase: NA
-
Varenicline in Combination With Nicotine Replacement Therapy for Smoking Cessation
NCT01444131 ·Status: COMPLETED ·Phase: PHASE2
-
A Comprehensive Evaluation of Tobacco-Flavored vs. Non-Tobacco Flavored E-cigarettes on Smoking Behavior
NCT06260683 ·Status: RECRUITING ·Phase: NA
-
Effects of Electronic Cigarette Use on the Lungs
NCT02596685 ·Status: COMPLETED ·Phase: NA
-
Nicotine Replacement Therapy (NRT) and Bupropion Mechanisms of Effectiveness in Smokers
NCT01048944 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Varenicline in Ambivalent Smokers
NCT00595868 ·Status: COMPLETED ·Phase: PHASE2
-
A 52-Week Placebo-Controlled Study Evaluating the Safety of Varenicline
NCT00143299 ·Status: COMPLETED ·Phase: PHASE3
-
STEPS: Substance Use Trial of E-cigarettes or Pharmacotherapy for Smoking
NCT06922617 ·Status: RECRUITING ·Phase: NA
-
Feasibility of Treatment for Vaping Cessation
NCT04317300 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Varenicline or Nicotine Patch in Promoting Smoking Cessation Among Current Smokers
NCT01771627 ·Status: COMPLETED ·Phase: NA
-
Adaptive Pharmacotherapy for Smoking Cessation
NCT02501265 ·Status: COMPLETED ·Phase: PHASE2
-
Trial of Varenicline With Nicotine Lozenges and a Smartphone Medication Adherence Intervention for Smoking Cessation
NCT07099638 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Study of Cytisinicline for Vaping Cessation in Adult Smokers
NCT05431387 ·Status: COMPLETED ·Phase: PHASE2
-
Nicotine Reinforcement and Aversion in Young Adult Light Smokers
NCT01495819 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Varenicline for Treatment of E-cigarette Dependence
NCT05541497 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of NicVAX in Smokers Who Want to Quit Smoking
NCT00318383 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Trial of Smoking Cessation Mobile Phone Program
NCT02656745 ·Status: COMPLETED ·Phase: NA
-
Smoking Cessation Study In Healthy Adolescent Smokers
NCT01312909 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Determine if a New Nicotine Replacement Therapy Can Safely Help Smokers to Quit Smoking
NCT01296698 ·Status: TERMINATED ·Phase: PHASE3
-
A 52-Week Multicenter Study Evaluating the Safety and Efficacy of Varenicline for the Maintenance of Smoking Cessation
NCT00143286 ·Status: COMPLETED ·Phase: PHASE3
-
Non-Nicotine Agents for Smoking Cessation
NCT00108537 ·Status: COMPLETED ·Phase: PHASE3
-
Chantix & Bupropion for Smoking Cessation
NCT00587769 ·Status: COMPLETED ·Phase: PHASE3